MLBTR Podcast: Twins And Orioles’ Injuries, The Guardians And Angels’ Quiet Offseasons, And Chris Sale’s Extension
The latest episode of the MLB Trade Rumors Podcast is now live on Spotify, Apple Podcasts, and wherever you get your podcasts! Make sure you subscribe as well! You can also use the player at this link to listen, if you don’t use Spotify or Apple for podcasts.
This week, host Darragh McDonald is joined by Steve Adams of MLB Trade Rumors to discuss…
- Twins right-hander Pablo López requiring Tommy John surgery (3:20)
- The Orioles losing Jordan Westburg due to a partially torn UCL in his elbow (13:15)
- The Guardians signing Rhys Hoskins to a minor league deal but doing little else this winter (23:45)
- Angels owner Arte Moreno making some curious statements (35:50)
- The Braves and Chris Sale signing an extension (47:35)
- Tony Clark resigning as executive director of the MLBPA and being replaced by Bruce Meyer (53:40)
Check out our past episodes!
- The Tigers’ Rotation, A Brewers-Red Sox Trade, And Late Free-Agent Signings – listen here
- Twins Front Office Shake-Up, The Brendan Donovan Trade, Eugenio Suarez, And More! – listen here
- Examining MLB’s Parity Situation – Also, Bellinger, Peralta, Robert, And Gore – listen here
The podcast intro and outro song “So Long” is provided courtesy of the band Showoff. Check out their Facebook page here!
Photo courtesy of Jonah Hinebaugh, Imagn Images
Braves Extend Chris Sale
The Braves announced Tuesday that they’ve signed veteran left-hander Chris Sale to a one-year, $27MM contract extension with a $30MM club option for the 2028 season. (Atlanta is one of the few teams that publicly discloses contract terms itself.) The Wasserman client was slated to reach free agency this coming winter but will instead stick with Atlanta through at least 2027.
Sale, 37 next month, is entering his late thirties but remains as effective as ever. Atlanta acquired the southpaw prior to the 2024 season in exchange for Vaughn Grissom in a deal with the Red Sox that turned out to be a coup. Since joining the organization, Sale has pitched to an otherworldly 2.46 ERA (2.84 SIERA, 2.38 FIP), with a strikeout rate of 32.2% and a walk rate of 5.9%. Those elite rate stats earned him his first career Cy Young Award in 2024, although a ribcage fracture in 2025 has limited his overall workload in Georgia to a total of 303 1/3 innings.
Injuries were the story of Sale’s career for several years prior to his arrival in Atlanta. For the first nine years of his big league tenure, the lefty was utterly elite with seven All-Star appearances and six top-five finishes in Cy Young voting for the White Sox and Red Sox.
That portion of his career ended in emphatic fashion as Sale struck out then-Dodger Manny Machado to secure the 2018 World Series for Boston, but come 2019 Sale struggled for the first time in his career. While his peripherals remained elite, he posted a pedestrian 4.40 ERA and was limited to just 25 starts due to injuries. He’d go on to make just nine starts between 2020 and 2022 before returning to the mound for most of the 2023 season with a 4.30 ERA in 20 starts.
Sale may not be a true workhorse, but he’s been more durable in recent seasons and will now look to continue the high note he’s found in Atlanta as his career begins to wind down. Both Sale himself and president of baseball operations Alex Anthopoulos recently indicated to reporters (including MLB.com’s Mark Bowman) that they hoped the remainder of the 2024 Cy Young winner’s career would be spent in Atlanta, and now he’ll remain under club control until the end of his age-39 campaign. Sale told reporters (including Chad Bishop of the Atlanta Journal-Constitution) after news of the extension broke this morning that the deal came together quickly after those comments were made early in camp.
“[Anthopoulos] said what he said, I said what I said, and we just kind of looked at each other like, ‘Are we serious?'” Sale said, as relayed by Bishop. “And I called [my agent] and was like ‘Hey, call Alex, figure something out.’ You know, we made our pitch, they made their pitch, and we just kind of met in the middle. I mean, I feel like this was [done in] like, a week.”
Sale will be looking to not only put the finishing touches on a compelling Hall of Fame case but also lead the Braves back into the postseason after a rough 2025 season. He’s the undisputed ace of an Atlanta staff that looks very intimidating when at full strength but now figures to enter the season without either Spencer Schwellenbach or Hurston Waldrep. Both young righties had surgery to remove bone spurs/loose bodies from their right elbows earlier this month, and neither has a clear timetable for his return.
Instead, Sale will be joined by Spencer Strider, Grant Holmes, and Reynaldo Lopez in the rotation as things stand, with a handful of depth arms in competition for the fifth starter job. It’s a group that could clearly use an additional quality arm, but it remains to be seen if Anthopoulos will manage to add someone like that to the mix before the season begins. Whatever may happen with the rotation in 2025, however, the Braves can now move forward with the assurance that one of the game’s most elite hurlers will be staying in town for the foreseeable future.
From a payroll vantage point, there doesn’t appear to be any immediate impact on the 2026 season. The contract is structured as a new deal beginning in 2027, so it doesn’t change Atlanta’s baseline cash payroll or its luxury tax payroll for the upcoming season.
Sale’s deal does tack on $27MM of luxury considerations to the 2027 budget, although the Braves already had substantial money coming off the books at season’s end. Ha-Seong Kim ($20MM), Raisel Iglesias ($16MM), Joe Jimenez ($9MM), Aaron Bummer ($9.5MM), Mauricio Dubón ($6.1MM), Jonah Heim ($1.25MM) and Jorge Mateo ($1MM) are all free agents at season’s end, and the only notable arbitration raise Atlanta faces will be Schwellenbach’s first trip through the process. As things stand, RosterResource projects a $176MM luxury payroll for Atlanta in 2027 — about $84MM shy of their current mark.
ESPN’s Jeff Passan first reported the extension and the 2027 salary.
MLBTR Podcast: An Agent’s Perspective with B.B. Abbott – Also, Cease, Williams, Helsley, And Gray
The latest episode of the MLB Trade Rumors Podcast is now live on Spotify, Apple Podcasts, and wherever you get your podcasts! Make sure you subscribe as well! You can also use the player at this link to listen, if you don’t use Spotify or Apple for podcasts.
This week, host Darragh McDonald is joined by B.B. Abbott of Wasserman Baseball to discuss…
- Abbott’s approach to free agency (3:30)
- The impact of the media on free agency (10:00)
- The different levels of player involvement in free agency (17:00)
- The decision to sign an extension instead of going to free agency (20:15)
- Chris Sale and his extensions with the White Sox, Red Sox and Braves (23:00)
- Byron Buxton and his extension with the Twins (28:50)
- Representing young players going into the draft (32:10)
- The general state of baseball (35:50)
Plus, Anthony Franco of MLB Trade Rumors joins the show to discuss…
- The Blue Jays signing Dylan Cease to a seven-year deal, recorded prior to the Cody Ponce agreement (40:30)
- The Mets agreeing to a three-year deal with Devin Williams (50:50)
- The Orioles signing Ryan Helsley to a two-year deal (55:40)
- The Cardinals trading Sonny Gray to the Red Sox for Richard Fitts and Brandon Clarke (1:06:30)
Check out our past episodes!
- Some “Classic Baseball Trades,” Nimmo For Semien, And Ward For Rodriguez – listen here
- Offseason Preview Megapod: Top 50 Free Agents – listen here
- Surprising Option Decisions, Qualifying Offers, And Paul DePodesta – listen here
The podcast intro and outro song “So Long” is provided courtesy of the band Showoff. Check out their Facebook page here!
Photo courtesy of Jerome Miron, Imagn Images
Braves To Exercise Club Option On Chris Sale
The Braves are exercising their club option on left-hander Chris Sale, according to a report from Jon Heyman of The New York Post. Sale will make $18MM in 2026.
The call to pick up Sale’s option for the 2026 campaign is surely one of the easiest option decisions any team will make this offseason. Sale, 36, is one of the best pitchers of his generation and won the NL Cy Young award in 2024. He was on track to compete for the award again this year, with a 2.52 ERA and 2.71 FIP through 15 starts, but he found himself sidelined for ten weeks over the summer due to a ribcage fracture. He looked just as dominant as ever when he returned, however, with a 2.72 ERA and 2.58 FIP across six starts in August and September. His stuff looked just as good as ever down the stretch, and he struck out an eye-popping 36.4% of his opponents in his 36 1/3 innings of work.
That Sale is pitching well is hardly a surprise, as he’s put together a Hall of Fame-caliber resume over the years. A nine-time All-Star who placed in the top five for AL Cy Young award voting six times before winning the NL award last year, Sale’s career 3.01 ERA, 2.88 FIP, and 30.8% strikeout rate know few equals throughout the game. He’s seventh all-time in strikeout rate among starting pitchers, and his run prevention and peripheral numbers match up well with titans of the sport like Clayton Kershaw and Pedro Martinez despite some of his counting numbers being held back by a relative lack of volume.
Fortunately, that relative lack of volume also means a relative lack of mileage on his arm, as compared to other players in his age range. Even with his 37th birthday on the horizon in March, Sale figures to serve as the club’s ace once again in 2026. He’ll be at the front of an Atlanta rotation with a lot of exciting upside but precious little certainty. Spencer Strider has shown the capacity to be a Cy Young caliber arm in the past, but had a disappointing 4.45 ERA in 2025. Spencer Schwellenbach has a career 3.23 ERA but was sidelined after just 17 starts this past season. Reynaldo Lopez had a 1.99 ERA in 2024 but didn’t appear in a game after March 28th this year.
Adding at least one proven, reliable rotation arm to this group figures to be a priority for the Braves this offseason, though it’s possible they could look to do more than that given the group’s collective injury history and questions about Lopez’s ability to handle the workload of a starter long-term. Even with additions likely on the horizon, though, there’s little doubt that Sale will be making his seventh career Opening Day start (and second for the Braves) in 2026 as long as he completes Spring Training with a clean bill of health.
Braves To Activate Chris Sale On Saturday
After more than two months on the injured list, ace southpaw Chris Sale is set to make his return to the mound next weekend. David O’Brien of The Athletic relays that Sale is “penciled in” to be activated from the injured list and take the ball for Saturday’s game against the Phillies. Sale is on the 60-day injured list, so the Braves will need to clear a 40-man roster spot to accommodate his return once it becomes official.
The 59-71 Braves are ten games out of a Wild Card spot and have virtually no hope of making a run to the postseason at this point. Sale’s return isn’t likely to change that, but getting the 36-year-old veteran starts down the stretch will nonetheless be important for the likely future Hall of Famer personally. Sale is no stranger to injuries; his 2024 Cy Young award winning campaign saw him make 29 starts, his highest total since 2017. Through his first 15 starts of this year, Sale seemed to have not missed a beat: he pitched to a phenomenal 2.52 ERA with a 2.69 FIP and a phenomenal 30.8% strikeout rate.
Unfortunately, a ribcage fracture sidelined Sale back in June. He’s been out of the club’s rotation ever since, and in that time has become one among a pile of injured starters the Braves have been forced to replace. Reynaldo Lopez and AJ Smith-Shawver both hit the injured list with season-ending ailments before Sale got hurt, and since Sale’s injury that trio has been joined by Spencer Schwellenbach (fractured elbow) and Grant Holmes (elbow inflammation). Sale is the only one expected to return among that group this season, and when he arrives this weekend he’ll join Spencer Strider and top prospect Hurston Waldrep at the top of the Atlanta rotation. Behind that trio, Brian Snitker will like rotate between some combination of Joey Wentz, Bryce Elder, and recent waiver claim Cal Quantrill with Dane Dunning and Didier Fuentes also in the mix as potential depth options.
If Sale can return for five or six healthy and effective starts down the stretch, that should put him in a good position to have a normal offseason and once again be a fixture of the Atlanta rotation come 2026. With Marcell Ozuna and Raisel Iglesias both set to reach free agency and the club poised to miss the postseason for the first time since 2017, this offseason could be one that sees significant change come to the Braves organization. With so many homegrown players signed to long-term contracts, however, it could prove somewhat difficult to retool the roster in a substantial way. Listening to offers on a rental ace like Sale could be one way to accomplish that, but it seems unlikely that will even be considered given Atlanta’s firm position against making their ace available at the deadline.
Braves Notes: Jimenez, Holmes, Sale
Joe Jiménez has been out all season after undergoing left knee surgery last November. The Braves reliever is now nine months removed from a procedure that came with an 8-12 month timeline. Jiménez had been throwing but was shut back down after experiencing soreness in his knee, manager Brian Snitker said yesterday (relayed by Barrett Sallee of 680 The Fan).
It now seems there’s a good chance Jiménez won’t pitch at all this season. This is a lost year for Atlanta. There’s little incentive to push Jiménez through discomfort. The 30-year-old righty would surely love to get back on the mound so he can go into the offseason with some normalcy, but the Braves aren’t going to take any chances.
Jiménez had the best year of his career in 2024. He threw a personal-high 68 2/3 innings with a 2.62 ERA. He recorded a career-best 27 holds while striking out nearly 30% of batters faced. It was an excellent start to his three-year, $26MM free agent deal. The injury unfortunately robbed him of most (potentially all) of year two. He’s signed for $9MM next season.
Atlanta is likely to see Raisel Iglesias depart in free agency. They’ll exercise their $7MM club option to retain Pierce Johnson, barring a late-season injury. Aaron Bummer and Dylan Lee will also be back. The rest of the relief group is in question. Daysbel Hernández has a 2.25 ERA but has walked almost 20% of opponents. Atlanta acquired Tyler Kinley from Colorado last week. That suggests they’ll at least consider bringing him back on a $5MM team option, but he hasn’t managed particularly good numbers since 2022. The Braves will likely need two or three external bullpen pickups on top of a healthy return from Jiménez.
While the Braves haven’t officially ruled Jiménez out for the season, starter Grant Holmes is definitely done for the year. Atlanta almost immediately placed him on the 60-day injured list when he went down with an elbow injury before the trade deadline. The Braves later diagnosed the issue as a partially torn ulnar collateral ligament. That has the potential to be a precursor to surgery, but Holmes told reporters (including David O’Brien of The Athletic) that he’ll attempt to rehab without going under the knife.
“If I can avoid the knife as long as possible, that’s the route I want to take,” the 29-year-old righty said. “I haven’t had any surgeries yet, thankfully, and I’m trying to keep it that way.” Holmes added that he’ll be on a no-throw program for at least six weeks and expressed his hope that he could resume throwing simulated games in November. He pointed out that undergoing Tommy John or internal brace surgery now would almost certainly cost him the entire 2026 season regardless. Holmes therefore felt he didn’t have much to lose in trying a non-surgical approach and evaluating how his elbow feels in a few months. If it doesn’t progress as hoped, he could undergo surgery early in the offseason and still set a goal of coming back at the start of the ’27 campaign.
Before the injury, Holmes was a bright spot in Atlanta’s nightmare season. He turned in a 3.99 ERA while striking out a quarter of opponents across 22 appearances. Holmes had impressed last season as a rookie but worked more often in long relief. He showed this season that he can be a capable mid-rotation starter as long as he’s healthy. Holmes is one of five Atlanta starters dealing with a long-term injury. They already lost AJ Smith-Shawver to Tommy John surgery, and it’d be a surprise if Spencer Schwellenbach returns from a broken elbow this year. Reynaldo López has been out almost all year after undergoing arthroscopic shoulder surgery.
Chris Sale, out since mid-June with a ribcage fracture, is the only one of that quintet who seems very likely to make it back this season. Sale is set to throw a live batting practice session on Thursday (via the MLB.com injury tracker). He’s not far off a minor league rehab assignment and could return from the 60-day IL before the end of the month. That’d allow the reigning NL Cy Young winner to make five or six starts to close the season. It won’t mean anything in the standings, but it’d give the Braves some confidence entering an offseason in which they’ll face questions about everyone in the rotation aside from Spencer Strider. Atlanta will retain Sale on an $18MM club option for what’ll be his age-37 season.
Latest On Braves’ Deadline Approach
The Braves have been in a downward spiral for much of the season. They’ve shown signs of life at various points, but those brief flashes were quickly stamped out by repeated injuries to star players. Atlanta lost Reynaldo Lopez to arthroscopic shoulder surgery in mid-April and was without both Spencer Strider and Ronald Acuña Jr. to begin the season. That All-Star duo has since returned, but over the past month the Braves have lost Chris Sale (fractured ribs), Spencer Schwellenbach (fractured elbow) and AJ Smith-Shawver (Tommy John surgery). Setup man Joe Jimenez underwent knee surgery in the offseason and is likely to miss the entire year as well.
On top of that brutal slate of pitching injuries, the Braves have seen several key players take major steps back in performance. Ozzie Albies and Michael Harris II have been two of baseball’s least-productive hitters. Closer Raisel Iglesias, fresh off a career-best year in 2024, is having a career-worst season in 2025 — although he’s recently rattled off 10 2/3 shutout innings with a 15-to-1 K/BB ratio, so perhaps he’s coming around. Austin Riley and Marcell Ozuna are both hitting better than the league-average hitter but worse than their career norms. Jurickson Profar missed 80 games due to a PED suspension.
The result is a 40-52 team that sits 13.5 games out of the division lead and 10 games back in the Wild Card hunt. FanGraphs gives Atlanta a 3.7% chance of making the postseason, which feels charitable for a club that presently has three healthy starters (Strider, Grant Holmes and Bryce Elder). The Braves rushed prospect Didier Fuentes to the majors just three days after his 20th birthday and despite having just 26 1/3 innings above A-ball under his belt. Predictably, it has not gone well (13.85 ERA in four starts).
The stage is set for Atlanta to operate in an unfamiliar manner this deadline, playing the role of a seller. President of baseball operations Alex Anthopoulos emphatically denounced the notion of even considering a trade of Sale last month, just prior to the left-hander’s injury. Anthopoulos called any speculation regarding a Sale trade “completely ridiculous” in an appearance on 680 The Fan in Atlanta.
“I never make definitive statements unless I’m going to stick to them,” he said at the time. “Once you make definitive statements and then you go back on them, you’re a liar and you’re done. [A trade of Sale] Will. Not. Happen. Bold, italicize it, caps.”
Even with the tumult that’s followed those statements — which predated not only Sale’s injury but also the Schwellenbach injury — the thinking doesn’t appear to have changed. Robert Murray of FanSided reports that the Braves have not discussed Sale in any trade talks and, furthermore, do not intend to listen on any player who’s controlled beyond the 2025 season.
[Related: Atlanta Braves Trade Deadline Outlook]
If that’s indeed the case, the Braves will be in for a quiet deadline. Atlanta only has three true free agents at season’s end: Iglesias, Ozuna and right-hander Rafael Montero. Any of the three could hold appeal on the market.
Iglesias, as noted, has had an uneven season but turned a corner of late. He’s sitting on a 4.67 ERA overall, but that’s a function of the 35-year-old’s 6.75 ERA through early June. Even as Iglesias struggled to those ugly results, however, he posted strong strikeout and walk rates. He was dogged by a .348 average on balls in play and a sky-high 21.9% homer-to-flyball rate along the way, but metrics like SIERA (3.34) still pegged him as a quality reliever and hinted at positive regression. Iglesias hasn’t markedly changed up his pitch selection, but he’s now missing far more bats in the zone and has recorded a colossal 20.7% swinging-strike rate over the course of his current hot streak.
That’s probably enough to drum up legitimate trade interest, especially when considering his track record. The right-hander has a 2.96 ERA and 233 saves in a career that spans more than a decade. From 2020-24, he posted an ERA of 2.74 or better each season, combining for a 2.44 mark with a 31.6% strikeout rate and 5.4% walk rate. This year’s $16MM salary is steep, but there will “only” be $5.333MM of that sum left come deadline day. (As of this writing, it’s $6.795MM.)
As for the 34-year-old Ozuna, he’s having a solid season at the plate but isn’t hitting anywhere near his 2023-24 levels. This year’s .236/.363/.385 slash is 14% better than league-average in the estimation of wRC+, a far cry from the 48% gap between Ozuna and the average MLB hitter in ’23-’24. Ozuna’s bat speed has dipped by 1.5 mph since 2023, per Statcast, dropping him from the 86th percentile of big league hitters to the 73rd. This year’s 42% ground-ball rate is his highest mark since 2019, while his 13.3% homer-to-flyball rate is his lowest since 2021.
Ozuna is also just swinging far, far less than in recent seasons. He offered at nearly 48% of the pitches he saw in 2023-24 but has swung at just 39.4% of the pitches he’s seen so far in 2025. That’s led to a major jump in walk rate, with the slugger sitting on a career-high 16.4% mark, but that selectivity has resulted in a dip in power output — both on a rate basis and in terms of totality.
While Iglesias has been rebuilding trade value as the summer wears on, Ozuna has been doing the opposite. He’s mired in one of the worst slumps of his career, hitting just .161/.254/.250 over his past 143 plate appearances dating back to early June. He’s still walked at a 10.5% clip along the way and has a roughly average strikeout rate (22.4%), but he’s hitting even more grounders in that stretch and has seen his quality of contact decline. Ozuna is making the same $16MM as Iglesias this season.
The only other pure rental on Atlanta’s roster is the 34-year-old Montero. The Braves surprisingly bailed the Astros out of nearly $3MM of Montero’s ill-fated three-year, $34.5MM contract when they acquired him early this season. He’s pitched decently, logging a 3.86 ERA in 28 innings but walking 12.8% of the batters he’s faced since being traded. He’s had better command recently, issuing just four walks to his past 74 hitters faced, however. With Houston on the hook for the majority of this year’s $11.5MM salary, Montero could hold appeal to teams looking for affordable bullpen help but unwilling to sacrifice top-end prospects to acquire it.
Other clubs will surely try to test the Braves’ resolve when it comes to dealing players controlled beyond the current season. Catcher Sean Murphy has been oft-speculated as a possible trade candidate thanks to the emergence of rookie catcher Drake Baldwin, though Ken Rosenthal of The Athletic recently reported that any such trade is likelier to occur in the offseason. Murphy is signed through 2028 and will be paid $15MM in each of the next three seasons.
Atlanta also has a pair of quality relievers with limited club control remaining in lefty Aaron Bummer (signed for next year at $9.5MM) and righty Pierce Johnson ($7MM club option for 2026). Both are having very strong seasons and will draw interest. Relievers are notoriously volatile, which could tempt Atlanta if another club presents a compelling offer. David O’Brien of The Athletic wrote this morning that the Braves could listen on Johnson, who has a 2.76 ERA, a 27.9% strikeout rate, a 7% walk rate and a 39% grounder rate in 32 2/3 innings. He’s picked up six holds and a save on the season.
There are perhaps larger-scale decisions coming down the pipe with regard to Albies — a former All-Star and Silver Slugger winner who’s batting just .221/.292/.320 in 391 plate appearances. His incredibly affordable club options for the 2026-27 seasons — $7MM apiece — make him a compelling rebound/change-of-scenery candidate.
It’d be tough for the Braves to decline his 2026 option, as it comes with a hearty $4MM buyout, rendering Albies a net $3MM decision. Even if the Braves hope to move on, it’s easy to imagine another club being interested in buying low at that price on what would be Albies’ age-29 and age-30 seasons. MLBTR readers were recently split nearly evenly in a poll on Albies’ future, with 54% saying the Braves should hold and hope for a rebound while 46% indicated that they should trade him, either now or in the offseason.
Pirates Trade Hunter Stratton To Braves
The Braves acquired right-handed reliever Hunter Stratton from the Pirates in exchange for minor league outfielder Titus Dumitru and cash, the teams announced Tuesday. Pittsburgh had designated Stratton for assignment last week. Atlanta transferred Chris Sale to the 60-day IL to open a 40-man roster spot for Stratton, who has been optioned to Triple-A Gwinnett.
Stratton, 28, has an unsightly 23.63 earned run average in the majors this year. However, that has come in a tiny sample of 2 2/3 innings. Over the 2023 and 2024 seasons, he had a combined 3.26 ERA in 49 2/3 innings. His 21% strikeout rate and 41% ground ball rate were both around average while his 4.9% walk rate was quite strong.
Though his major league ERA is through the roof this year, his minor league work has largely been in line with his pre-2025 results. In 24 2/3 Triple-A innings this year, he has a 3.65 ERA, 23.8% strikeout rate, 7.9% walk rate and 50% ground ball rate. He still has a full slate of options, though is burning through the first of those here in 2025.
For a pitcher with solid results and roster flexibility, it was a bit surprising that the Pirates gave up on him. But unsurprisingly, there has been enough interest that Atlanta has forfeited a prospect in order to skip the waiver line and add some bullpen depth.
Dumitru, 22, was selected by Atlanta in the 16th-round of last year’s draft. He played at the Single-A level last year and has been at High-A this year. Put together, he has played in 91 professional games with a .227/.314/.324 line and 97 wRC+.
Sale was placed on the 15-day IL a little over a week ago due to a rib cage fracture. The club didn’t provide many details about his expected absence at that time, but it seemed fair to expect he wouldn’t be back anytime soon. Today’s transfer confirms that the club doesn’t expect him back until mid-August at the earliest.
For now, Atlanta is operating with a rotation consisting of Spencer Strider, Spencer Schwellenbach, Grant Holmes, Bryce Elder and Didier Fuentes. Adding to that group would be a priority for the club if they plan on being deadline buyers. President of baseball operations Alex Anthopoulos is hoping to bolster the club rather than subtract from it but they are currently in a tough spot, 7.5 games back of a playoff spot. They have some time to climb but doing so without Sale, Reynaldo López and AJ Smith-Shawver will be a challenge. On the other hand, if they hang in there, it’s possible Sale and López could be back later in the year.
Photo courtesy of Michael McLoone, Imagn Images
MLBTR Podcast: The Braves Say They Won’t Sell, Jeimer Candelario DFA’d, And Injured D-Backs
The latest episode of the MLB Trade Rumors Podcast is now live on Spotify, Apple Podcasts, and wherever you get your podcasts! Make sure you subscribe as well! You can also use the player at this link to listen, if you don’t use Spotify or Apple for podcasts.
This week, host Darragh McDonald is joined by Anthony Franco of MLB Trade Rumors to discuss…
- MLBTR’s new Trade Deadline Outlook series for Front Office subscribers having kicked off with the Pirates, Phillies and Marlins (2:00)
- Alex Anthopoulos says the Braves won’t sell but now Chris Sale is injured (8:55)
- The Reds designating Jeimer Candelario for assignment and calling up Chase Burns (12:40)
- The Diamondbacks’ situation exacerbated by injuries to A.J. Puk, Gabriel Moreno and Corbin Carroll (19:50)
Plus, we answer your questions, including…
- Matthew Boyd has already surpassed his highest innings total since 2019. How far do the Cubs push him over the remainder of the season? (32:05)
- The Padres and Royals have pitching they could trade but should they? (38:20)
- The Reds don’t have long-term answers at first base, third base, left field, right field or designated hitter. Is there a path to bring in players from outside the organization? (45:40)
Check out our past episodes!
- Reacting To The Devers Trade And Aaron Civale – listen here
- White Sox Ownership, Roman Anthony, And The Diamondbacks’ Rotation – listen here
- Jarren Duran Rumors, Caglianone And Young Promoted, And Pitching Injuries – listen here
The podcast intro and outro song “So Long” is provided courtesy of the band Showoff. Check out their Facebook page here!
Photo courtesy of Robert Edwards, Imagn Images
Braves Place Chris Sale On 15-Day IL With Ribcage Fracture
The Braves announced this afternoon that they’ve placed southpaw Chris Sale on the 15-day injured list with what the club has termed a fractured left ribcage. The club recalled left-hander Austin Cox in a corresponding move. As noted by David O’Brien of The Athletic, Sale was injured on Wednesday night when he made a diving play to stop a grounder off the bat of Juan Soto.
It’s a brutal blow for Atlanta to be dealt, particularly following a banner week that saw them sweep the then-division leading Mets and get within five games of an NL Wild Card spot. They’ve won seven of their last ten games, but if they’re going to keep that momentum going in a bid to get back over .500 and more firmly return to playoff contention they’ll now need to do so without Sale for the time being. The reigning NL Cy Young award winner, Sale has built on his brilliant 2024 season with a 2025 campaign that’s been nearly as good. Across 15 starts this year, the 36-year-old has pitched to a brilliant 2.52 ERA with a 2.65 FIP across 89 1/3 innings of work.
He’s struck out a phenomenal 30.8% of his opponents while walking just 7.0%. Those excellent peripherals have left him with a 2.96 SIERA, making him one of just seven qualified starters in baseball this year with a figure under three. Only Logan Webb and Paul Skenes are having better seasons by measure of ERA, and Sale is doing all of that despite terrible batted ball luck: his .329 BABIP allowed is the fourth-highest figure among qualified starters in the majors this year. It’s been another banner year for the southpaw, who has looked rejuvenated in Atlanta after injury-marred seasons with the Red Sox from 2019 to 2023.
Unfortunately, that resurgence is now put on hold by another significant injury. Sale’s timetable for a return to action is not yet known at this point, but it’s worth noting that a stress fracture in Sale’s right ribs cost him the first half of the 2022 season. After being sidelined in mid-March by the injury, Sale did not return to the mound until early July. A similar timeline would put the remainder of the southpaw’s 2025 campaign in danger, but it’s important to note that it’s unclear if Sale’s current rib cage fracture is as severe as the rib issue he dealt with in 2022.
However long the ace’s absence ultimately ends up being, it leaves Atlanta with a rotation mix that’s stretched very thin. The team is already without Reynaldo Lopez for the foreseeable future after he underwent shoulder surgery earlier this year, and AJ Smith-Shawver is done for the season after undergoing Tommy John surgery. Spencer Schwellenbach and Spencer Strider will attempt to hold things down at the front of the rotation in Sale’s absence, while Grant Holmes and Bryce Elder will look to handle mid-rotation duties. Rookie Didier Fuentes currently holds the fifth starter job after making a spot start against the Marlins yesterday, but another starer like Hurston Waldrep, Davis Daniel, or even Ian Anderson could also be called upon to help round out the rotation mix.